SK Bioscience Co Ltd (302440) — Free Cash Flow Generation Index
SK Bioscience Co Ltd (302440) has a Free Cash Flow Generation Index of -2.44x as of September 2025. Free cash flow of ₩-50.29 Billion represents -2% of operating cash flow (₩20.65 Billion). See SK Bioscience Co Ltd (302440) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for SK Bioscience Co Ltd across 5 annual periods. Explore debt repayment capacity of SK Bioscience Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for SK Bioscience Co Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for SK Bioscience Co Ltd. For the full company profile including market capitalisation, see market cap of SK Bioscience Co Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.71x | ₩-20.95 Billion | ₩29.35 Billion | ₩50.30 Billion | ▼ -177.8% |
| 2021 | 0.92x | ₩492.12 Billion | ₩536.59 Billion | ₩42.91 Billion | ▲ +0.2% |
| 2020 | 0.92x | ₩110.03 Billion | ₩120.22 Billion | ₩9.93 Billion | ▲ +594.7% |
| 2019 | -0.19x | ₩-4.04 Billion | ₩21.82 Billion | ₩23.97 Billion | ▼ -132.1% |
| 2018 | 0.58x | ₩8.59 Billion | ₩14.90 Billion | ₩6.31 Billion | — |